Search Results - Craig W Hendrix
- Showing 1 - 16 results of 16
-
1
-
2
Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows non‐superiority for oral dosing, but promise as a subcutaneous implant by Hee‐yeong Kim, Lanxin Zhang, Craig W. Hendrix, Jessica E. Haberer, Max vonKleist
Published in CPT: Pharmacometrics & Systems Pharmacology (2024-10-01)Get full text
Article -
3
Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy by Rachel K. Scott, Yifan Yu, Mark A. Marzinke, Jenell S. Coleman, Craig W. Hendrix, Robert Bies
Published in Frontiers in Reproductive Health (2023-09-01)Get full text
Article -
4
Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis by Sandra Abdul Massih, Mohamed G. Atta, Chloe L. Thio, Jeffrey A. Tornheim, Edward J. Fuchs, Rahul P. Bakshi, Mark A. Marzinke, Craig W. Hendrix, Ethel D. Weld
Published in AIDS Research and Therapy (2024-05-01)Get full text
Article -
5
Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques by Peng Xiao, Sanjeev Gumber, Mark A. Marzinke, Thuy Hoang, Rohan Myers, Abhijit A. Date, Justin Hanes, Laura M. Ensign, Lin Wang, Lisa C. Rohan, Richard Cone, Edward J. Fuchs, Craig W. Hendrix, Francois Villinger
Published in JCI Insight (2022-12-01)Get full text
Article -
6
Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN‐003 (VOICE) study by Ariane van derStraten, Elizabeth R Brown, Jeanne M Marrazzo, Michael Z Chirenje, Karen Liu, Kailazarid Gomez, Mark A Marzinke, Jeanna M Piper, Craig W Hendrix, on behalf of the MTN‐003 VOICE Protocol Team for the Microbicide Trials Network
Published in Journal of the International AIDS Society (2016-01-01)Get full text
Article -
7
A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near‐term pregnancy by Richard H Beigi, Lisa M Noguchi, Elizabeth Montgomery, Joseph Biggio, Craig W Hendrix, Mark A Marzinke, James Y Dai, Jason Pan, Ratiya Kunjara Na Ayudhya, Jill L Schwartz, Karen Isaacs, Jeanna M Piper, D Heather Watts
Published in Journal of the International AIDS Society (2016-01-01)Get full text
Article -
8
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Pro... by Maria Garcia-Cremades, Craig W. Hendrix, Priya Jayachandran, Natasha Strydom, Leah Jarlsberg, Robert Grant, Connie L. Celum, Michael Martin, Jared M. Baeten, Jeanne Marrazzo, Peter Anderson, Kachit Choopanya, Suphak Vanichseni, David V. Glidden, Radojka M. Savic
Published in Pharmaceutics (2022-08-01)Get full text
Article -
9
Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates by Sravan Kumar Patel, Sravan Kumar Patel, Hrushikesh Agashe, Hrushikesh Agashe, Dorothy L. Patton, Yvonne Sweeney, May A. Beamer, Craig W. Hendrix, Sharon L. Hillier, Sharon L. Hillier, Lisa C. Rohan, Lisa C. Rohan, Lisa C. Rohan
Published in Frontiers in Reproductive Health (2023-08-01)Get full text
Article -
10
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings by Sharon L. Achilles, Clifton W. Kelly, Craig J. Hoesley, Diana L. Blithe, Jill Brown, Barbra A. Richardson, Brid Devlin, Craig W. Hendrix, Samuel M. Poloyac, Mark A. Marzinke, Holly Gundacker, Devika Singh, Jeanna M. Piper, Sherri Johnson, John Steytler, Beatrice A. Chen
Published in PLoS ONE (2024-01-01)Get full text
Article -
11
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel. by Marla J Keller, Rebecca P Madan, N Merna Torres, Melissa J Fazzari, Sylvia Cho, Sabah Kalyoussef, Gail Shust, Pedro M M Mesquita, Nicolette Louissaint, Jianmeng Chen, Hillel W Cohen, Erin C Diament, Anna C Lee, Lydia Soto-Torres, Craig W Hendrix, Betsy C Herold
Published in PLoS ONE (2011-01-01)Get full text
Article -
12
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study. by Lynn T Matthews, Esther C Atukunda, Moran Owembabazi, Kato Paul Kalyebera, Christina Psaros, Pooja Chitneni, Craig W Hendrix, Mark A Marzinke, Peter L Anderson, Oluwaseyi O Isehunwa, Kathleen E Hurwitz, Kara Bennett, Winnie Muyindike, David R Bangsberg, Jessica E Haberer, Jeanne M Marrazzo, Mwebesa Bosco Bwana
Published in PLoS Medicine (2023-02-01)Get full text
Article -
13
Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology de... by Barbara A. Friedland, Holly Gundacker, Sharon L. Achilles, Beatrice A. Chen, Craig Hoesley, Barbra A. Richardson, Clifton W. Kelly, Jeanna Piper, Sherri Johnson, Brid Devlin, John Steytler, Kyle Kleinbeck, Bindi Dangi, Chantél Friend, Mei Song, Barbara Mensch, Ariane van der Straten, Cindy Jacobson, Craig W. Hendrix, Jill Brown, Diana Blithe, Sharon L. Hiller
Published in PLoS ONE (2025-01-01)Get full text
Article -
14
Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 by Sinead Delany‐Moretlwe, Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya, Juliet Mpendo, Muchaneta Bhondai‐Mhuri, Nyaradzo Mgodi, Rebecca Berhanu, Jennifer Farrior, Estelle Piwowar‐Manning, Susan L. Ford, Craig W. Hendrix, Alex R. Rinehart, James F. Rooney, Adeola Adeyeye, Raphael J. Landovitz, Myron S. Cohen, Mina C. Hosseinipour, Mark A. Marzinke, the HPTN 084 Study Team
Published in Journal of the International AIDS Society (2025-01-01)Get full text
Article -
15
Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology de... by Barbara A Friedland, Holly Gundacker, Sharon L Achilles, Beatrice A Chen, Craig Hoesley, Barbra A Richardson, Clifton W Kelly, Jeanna Piper, Sherri Johnson, Brid Devlin, John Steytler, Kyle Kleinbeck, Bindi Dangi, Chantél Friend, Mei Song, Barbara Mensch, Ariane van der Straten, Cindy Jacobson, Craig W Hendrix, Jill Brown, Diana Blithe, Sharon L Hiller, MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network
Published in PLoS ONE (2025-01-01)Get full text
Article -
16
CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions by Laura E. Richert-Spuhler, Corinne M. Mar, Paurvi Shinde, Feinan Wu, Ting Hong, Evan Greene, Sharon Hou, Katherine Thomas, Raphael Gottardo, Nelly Mugo, Guy de Bruyn, Connie Celum, Jared M. Baeten, Jairam R. Lingappa, Jennifer M. Lund, Connie Celum, Anna Wald, Jairam R. Lingappa, Jared M. Baeten, Mary S. Campbell, Lawrence Corey, Robert W. Coombs, James P. Hughes, Amalia Magaret, M. Juliana McElrath, Rhoda Morrow, James I. Mullins, David Coetzee, Kenneth Fife, Edwin Were, Max Essex, Joseph Makhema, Elly Katabira, Allan Ronald, Elizabeth Bukusi, Craig Cohen, Saidi Kapiga, Rachel Manongi, Carey Farquhar, Grace John-Stewart, James Kiarie, Sinead Delany-Moretlwe, Helen Rees, Guy de Bruyn, Glenda Gray, James McIntyre, Nelly Rwamba Mugo, Connie Celum, Jared M. Baeten, Deborah Donnell, Robert W. Coombs, Lisa Frenkel, Craig W. Hendrix, Jairam R. Lingappa, M. Juliana McElrath, Kenneth Fife, Edwin Were, Elioda Tumwesigye, Patrick Ndase, Elly Katabira, Allan Ronald, Eliabeth Bukusi, Craig Cohen, Jonathan Wangisi, James Campbell, Jordan Tappero, James Kiarie, Carey Farquhar, Grace John-Stewart, Nelly Rwamba Mugo
Published in Cell Reports Medicine (2021-06-01)Get full text
Article